Perioperative blood pressure variability as a risk factor for postoperative delirium in the patients receiving cardiac surgery.
Xiao Shen, Hong Tao, Wenxiu Chen...
https://pubmed.ncbi.nlm.nih.gov/39581994/Actively Recruiting
Led by Saglik Bilimleri Universitesi Gazi Yasargil Training and Research Hospital · Updated on 2026-07-29
230
Participants Needed
1
Research Sites
2 weeks
Total Duration
This research aims to evaluate the impact of intraoperative hemodynamic instability during elective cardiac surgery on major postoperative complications. The study focuses on adult patients undergoing surgeries like coronary artery bypass grafting CABG, valve replacement or repair, or combined procedures using cardiopulmonary bypass. It investigates how low mean arterial pressure MAP < 65 mmHg or the need for vasopressors during surgery relates to outcomes such as delirium, acute kidney injury, stroke, or mortality. Participants are grouped based on whether they experience significant hemodynamic instability during surgery, defined as MAP below 65 mmHg for more than 5 minutes or requiring vasopressor support, versus those with stable intraoperative blood pressure. No interventions are assigned since this is a prospective observational study. The study collects detailed intraoperative data including MAP, heart rate, and vasopressor use, and follows patients for 30 days post-operation to assess adverse outcomes. During the study, participants undergo cardiac surgery with monitoring of their hemodynamics. Researchers assess major postoperative adverse events up to 30 days after surgery, including delirium using CAM-ICU, acute kidney injury per KDIGO criteria, stroke, and mortality. Secondary measures include duration of mechanical ventilation and lengths of ICU and hospital stay. The study is designed to provide evidence on blood pressure management thresholds to improve surgical outcomes, with a total follow-up period of 30 days after the operation.
CONDITIONS
Impact of Intraoperative Hemodynamic Instability on Outcomes in Cardiac Surgery
O
Osman Uzundere, M.D.
Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.
Already have an account? Log in here
Saglik Bilimleri Universitesi Gazi Yasargil Training and Research Hospital
Lead Sponsor
You may qualify if you...
You will not qualify if you...
Duration - 2 to 4 weeks
Participants are screened for eligibility to participate in the trial.
Duration - Up to 30 days post-operation
Participants undergo elective cardiac surgery with monitoring of blood pressure and medication use during the operation. After surgery, recovery and any complications are assessed for up to 30 days including delirium, kidney function, stroke, and mortality.
Study Type
OBSERVATIONAL
Masking
N/A
Allocation
N/A
Model
N/A
Primary Purpose
N/A
Number of Arms
2
Have more questions? Get in touch with our team for quick support
Xiao Shen, Hong Tao, Wenxiu Chen...
https://pubmed.ncbi.nlm.nih.gov/39581994/Filippo D'Amico, Evgeny V Fominskiy, Stefano Turi...
https://pubmed.ncbi.nlm.nih.gov/37739903/Edward Buitenwerf, Mats F Boekel, Marieke I van der Velde...
https://pubmed.ncbi.nlm.nih.gov/30624247/Saglik Bilimleri Universitesi Gazi Yasargil Training and Research Hospital
Lead Sponsor